The expanded agreement aims to deliver greater cost leadership and productivity enhancement for Gilead while seeking to extract greater value from the existing relationship. Leveraging machine ...

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the drug has shown promise being dosed even further apart at only once a year.

A new chief executive trying to steer the company, generative AI disrupting the information technology (IT) services industry, and now an activist shareholder raising its stake—New Jersey-based ...

Across the recent three months, 14 analysts have shared their insights on Gilead Sciences GILD, expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates ...

Gilead Sciences (GILD) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the ...

Mantle Ridge, led by American founder and CEO Paul Hilal, began purchasing Cognizant shares in the second half of 2022 when the stock was priced between $50 and $60 per share. The activist firm, which ...

Medical pioneer Gilead Sciences GILD has seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks. Gilead has joined Johnson & Johnson JNJ, and a cluster ...

Cognizant shares now trade at around $83 per share, giving the company a market value of more than $41 billion.

IT giant Infosys and Cognizant, a Nasdaq-listed firm, are engaged in a bitter legal battle in a court in Dallas. The dispute centres on allegations of trade secret misappropriation and ...

Gilead Sciences has a 52-week low of $62.07 and a 52-week high of $117.39. The firm’s 50 day moving average is $99.15 and its 200-day moving average is $91.09.

IT giant Cognizant staff in India will have to tarry for five months until August 2025 for their next hike. This is the second consecutive delay in increment at the company in two years. The delay was ...